Nilsson LM - Search Results

1

Cancer Differentiating Agent Hexamethylene Bisacetamide Inhibits BET Bromodomain Proteins.

Nilsson LM, Green LC, Muralidharan SV, Demir D, Welin M, Bhadury J, Logan DT, Walse B, Nilsson JA. Nilsson LM, et al. Among authors: nilsson ja. Cancer Res. 2016 Apr 15;76(8):2376-83. doi: 10.1158/0008-5472.CAN-15-2721. Epub 2016 Mar 3. Cancer Res. 2016. PMID: 26941288

2

Id2 is dispensable for myc-induced lymphomagenesis.

Nilsson JA, Nilsson LM, Keller U, Yokota Y, Boyd K, Cleveland JL. Nilsson JA, et al. Among authors: nilsson lm. Cancer Res. 2004 Oct 15;64(20):7296-301. doi: 10.1158/0008-5472.CAN-04-2133. Cancer Res. 2004. PMID: 15492249

3

Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation.

Nilsson JA, Keller UB, Baudino TA, Yang C, Norton S, Old JA, Nilsson LM, Neale G, Kramer DL, Porter CW, Cleveland JL. Nilsson JA, et al. Among authors: nilsson lm. Cancer Cell. 2005 May;7(5):433-44. doi: 10.1016/j.ccr.2005.03.036. Cancer Cell. 2005. PMID: 15894264 Free article.

4

Myc sensitizes p53-deficient cancer cells to the DNA-damaging effects of the DNA methyltransferase inhibitor decitabine.

Höglund A, Nilsson LM, Forshell LP, Maclean KH, Nilsson JA. Höglund A, et al. Among authors: nilsson ja, nilsson lm. Blood. 2009 Apr 30;113(18):4281-8. doi: 10.1182/blood-2008-10-183475. Epub 2009 Jan 29. Blood. 2009. PMID: 19179467 Free article.

5

Skp2 directs Myc-mediated suppression of p27Kip1 yet has modest effects on Myc-driven lymphomagenesis.

Old JB, Kratzat S, Hoellein A, Graf S, Nilsson JA, Nilsson L, Nakayama KI, Peschel C, Cleveland JL, Keller UB. Old JB, et al. Mol Cancer Res. 2010 Mar;8(3):353-62. doi: 10.1158/1541-7786.MCR-09-0232. Epub 2010 Mar 2. Mol Cancer Res. 2010. PMID: 20197382 Free PMC article.

6

The direct Myc target Pim3 cooperates with other Pim kinases in supporting viability of Myc-induced B-cell lymphomas.

Forshell LP, Li Y, Forshell TZ, Rudelius M, Nilsson L, Keller U, Nilsson J. Forshell LP, et al. Oncotarget. 2011 Jun;2(6):448-60. doi: 10.18632/oncotarget.283. Oncotarget. 2011. PMID: 21646687 Free PMC article.

7

Therapeutic implications for the induced levels of Chk1 in Myc-expressing cancer cells.

Höglund A, Nilsson LM, Muralidharan SV, Hasvold LA, Merta P, Rudelius M, Nikolova V, Keller U, Nilsson JA. Höglund A, et al. Among authors: nilsson ja, nilsson lm. Clin Cancer Res. 2011 Nov 15;17(22):7067-79. doi: 10.1158/1078-0432.CCR-11-1198. Epub 2011 Sep 20. Clin Cancer Res. 2011. PMID: 21933891

8

Mouse genetics suggests cell-context dependency for Myc-regulated metabolic enzymes during tumorigenesis.

Nilsson LM, Forshell TZ, Rimpi S, Kreutzer C, Pretsch W, Bornkamm GW, Nilsson JA. Nilsson LM, et al. Among authors: nilsson ja. PLoS Genet. 2012;8(3):e1002573. doi: 10.1371/journal.pgen.1002573. Epub 2012 Mar 15. PLoS Genet. 2012. PMID: 22438825 Free PMC article.

9

Identification of tumorigenic and therapeutically actionable mutations in transplantable mouse tumor cells by exome sequencing.

Bhadury J, López MD, Muralidharan SV, Nilsson LM, Nilsson JA. Bhadury J, et al. Among authors: nilsson ja, nilsson lm. Oncogenesis. 2013 Apr 15;2(4):e44. doi: 10.1038/oncsis.2013.8. Oncogenesis. 2013. PMID: 23588493 Free PMC article.

10

BET and HDAC inhibitors induce similar genes and biological effects and synergize to kill in Myc-induced murine lymphoma.

Bhadury J, Nilsson LM, Muralidharan SV, Green LC, Li Z, Gesner EM, Hansen HC, Keller UB, McLure KG, Nilsson JA. Bhadury J, et al. Among authors: nilsson ja, nilsson lm. Proc Natl Acad Sci U S A. 2014 Jul 1;111(26):E2721-30. doi: 10.1073/pnas.1406722111. Epub 2014 Jun 16. Proc Natl Acad Sci U S A. 2014. PMID: 24979794 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

146 results

Search Page